News | Peripheral Artery Disease (PAD) | October 12, 2016

Society for Vascular Surgery Announces New PAD Reporting Standards

Update of 1997 peripheral artery disease treatment standards reflects boom in endovascular devices and techniques

Society for Vascular Surgery, SVS, new PAD reporting standards, peripheral artery disease

October 12, 2016 — The Society for Vascular Surgery (SVS) has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease (PAD). Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.

The last decade has seen a tremendous increase in the variety of endovascular devices and techniques to treat occlusive disease, the report authors state, and “the literature surrounding therapy for endovascular arterial disease consists of mixed-quality manuscripts without clear standardization.”

This document clarifies and updates the 1997 standards, specifically for reports on endovascular treatment. The document is divided into sections:

  • Claudication Reporting;
  • Critical Limb Ischemia Reporting;
  • Pre-intervention Assessment and Non-anatomic Treatment;
  • Intervention;
  • Outcome Measures – Procedural; and
  • Outcome Measures – Disease Specific and Complications.

The document provides a summary for reporting endovascular revascularization techniques in the setting of chronic disease, with much of it based on prior publications and SVS-proposed standards.

It also should:

  • Serve as a guide for the design of clinical trials; and
  • Be a reference for journal editors and reviewers when considering scientific work pertaining to endovascular therapy for chronic lower extremity arterial disease.

The abstract of the standards can be read here.

For more information: www.jvascsurg.org


Related Content

News | Peripheral Artery Disease (PAD)

Feb. 3, 2025 — Today, Peripheral Artery Disease (PAD) affects 10 million Americans and is the most common cause of limb ...

Home February 04, 2025
Home
News | Peripheral Artery Disease (PAD)

Jan. 13, 2025 – R3 Vascular Inc., a medical device company dedicated to treating peripheral arterial disease (PAD) ...

Home January 13, 2025
Home
News | Peripheral Artery Disease (PAD)

A new study reports persistent disparities in outcomes for people with peripheral artery disease (PAD) and its more ...

Home January 13, 2025
Home
News | Peripheral Artery Disease (PAD)

Dec. 13, 2024 – Sensome has announced positive results from two studies of its Clotild Smart Guidewire System ...

Home December 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 18, 2024 — In November, Esperion presented an analysis from the CLEAR Outcomes study focused on patients with ...

Home December 03, 2024
Home
News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...

Home September 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...

Home September 04, 2024
Home
News | Peripheral Artery Disease (PAD)

May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...

Home May 16, 2024
Home
News | Peripheral Artery Disease (PAD)

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

Home May 08, 2024
Home
Subscribe Now